vs

Side-by-side financial comparison of AMERICAN SHARED HOSPITAL SERVICES (AMS) and Virginia National Bankshares Corp (VABK). Click either name above to swap in a different company.

Virginia National Bankshares Corp is the larger business by last-quarter revenue ($15.0M vs $7.7M, roughly 1.9× AMERICAN SHARED HOSPITAL SERVICES). Virginia National Bankshares Corp runs the higher net margin — 39.7% vs -8.2%, a 47.8% gap on every dollar of revenue. On growth, Virginia National Bankshares Corp posted the faster year-over-year revenue change (3.6% vs -14.8%). Virginia National Bankshares Corp produced more free cash flow last quarter ($20.8M vs $-2.7M). Over the past eight quarters, AMERICAN SHARED HOSPITAL SERVICES's revenue compounded faster (21.7% CAGR vs 7.0%).

American Shared Hospital Services offers turnkey outsourced solutions for advanced radiotherapy, stereotactic radiosurgery and diagnostic imaging equipment to healthcare facilities. It eliminates high upfront capital costs for hospitals, operates primarily across North America, and also serves Latin America and select Asia-Pacific markets, catering to both public and private hospital segments.

United Bankshares, Inc. is a bank holding company dual-headquartered in Charleston, West Virginia and Fairfax, Virginia with operations in West Virginia, Virginia, the District of Columbia, Maryland, Ohio, Pennsylvania, North Carolina, South Carolina, and Georgia in the United States. United Bankshares is the parent company of United Bank which comprises nearly 250 offices in eight states. In addition, UBSI is the parent company to subsidiaries George Mason Mortgage, United Brokerage, and Cre...

AMS vs VABK — Head-to-Head

Bigger by revenue
VABK
VABK
1.9× larger
VABK
$15.0M
$7.7M
AMS
Growing faster (revenue YoY)
VABK
VABK
+18.3% gap
VABK
3.6%
-14.8%
AMS
Higher net margin
VABK
VABK
47.8% more per $
VABK
39.7%
-8.2%
AMS
More free cash flow
VABK
VABK
$23.4M more FCF
VABK
$20.8M
$-2.7M
AMS
Faster 2-yr revenue CAGR
AMS
AMS
Annualised
AMS
21.7%
7.0%
VABK

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
AMS
AMS
VABK
VABK
Revenue
$7.7M
$15.0M
Net Profit
$-631.0K
$6.0M
Gross Margin
11.7%
Operating Margin
-18.1%
50.5%
Net Margin
-8.2%
39.7%
Revenue YoY
-14.8%
3.6%
Net Profit YoY
52.5%
30.6%
EPS (diluted)
$-0.09
$1.10

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AMS
AMS
VABK
VABK
Q4 25
$7.7M
$15.0M
Q3 25
$7.2M
$14.4M
Q2 25
$7.1M
$14.1M
Q1 25
$6.1M
$14.1M
Q4 24
$9.1M
$14.5M
Q3 24
$7.0M
$13.5M
Q2 24
$7.1M
$12.9M
Q1 24
$5.2M
$13.1M
Net Profit
AMS
AMS
VABK
VABK
Q4 25
$-631.0K
$6.0M
Q3 25
$-17.0K
$4.6M
Q2 25
$-280.0K
$4.2M
Q1 25
$-625.0K
$4.5M
Q4 24
$-1.3M
$4.6M
Q3 24
$-207.0K
$4.6M
Q2 24
$3.6M
$4.2M
Q1 24
$119.0K
$3.6M
Gross Margin
AMS
AMS
VABK
VABK
Q4 25
11.7%
Q3 25
22.1%
Q2 25
23.1%
Q1 25
15.4%
Q4 24
35.3%
Q3 24
19.6%
Q2 24
35.0%
Q1 24
41.1%
Operating Margin
AMS
AMS
VABK
VABK
Q4 25
-18.1%
50.5%
Q3 25
-4.8%
39.4%
Q2 25
-7.7%
38.4%
Q1 25
-21.3%
38.4%
Q4 24
-20.2%
40.3%
Q3 24
-12.7%
41.9%
Q2 24
-0.0%
39.5%
Q1 24
-1.6%
32.9%
Net Margin
AMS
AMS
VABK
VABK
Q4 25
-8.2%
39.7%
Q3 25
-0.2%
31.7%
Q2 25
-4.0%
30.0%
Q1 25
-10.2%
31.9%
Q4 24
-14.6%
31.4%
Q3 24
-3.0%
34.1%
Q2 24
51.0%
32.3%
Q1 24
2.3%
27.8%
EPS (diluted)
AMS
AMS
VABK
VABK
Q4 25
$-0.09
$1.10
Q3 25
$0.00
$0.84
Q2 25
$-0.04
$0.78
Q1 25
$-0.10
$0.83
Q4 24
$-0.21
$0.85
Q3 24
$-0.03
$0.85
Q2 24
$0.55
$0.77
Q1 24
$0.02
$0.68

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AMS
AMS
VABK
VABK
Cash + ST InvestmentsLiquidity on hand
$3.5M
Total DebtLower is stronger
$17.4M
Stockholders' EquityBook value
$24.0M
$184.2M
Total Assets
$55.5M
$1.6B
Debt / EquityLower = less leverage
0.72×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AMS
AMS
VABK
VABK
Q4 25
$3.5M
Q3 25
$5.1M
Q2 25
$11.1M
Q1 25
$11.2M
Q4 24
$11.0M
Q3 24
$13.8M
Q2 24
$14.2M
Q1 24
$12.8M
Total Debt
AMS
AMS
VABK
VABK
Q4 25
$17.4M
Q3 25
$18.2M
Q2 25
$19.1M
Q1 25
$19.9M
Q4 24
$20.4M
Q3 24
$14.4M
Q2 24
$15.1M
Q1 24
$15.6M
Stockholders' Equity
AMS
AMS
VABK
VABK
Q4 25
$24.0M
$184.2M
Q3 25
$24.6M
$177.4M
Q2 25
$24.5M
$170.8M
Q1 25
$24.6M
$166.8M
Q4 24
$25.2M
$160.3M
Q3 24
$26.4M
$165.9M
Q2 24
$26.5M
$154.2M
Q1 24
$22.8M
$152.6M
Total Assets
AMS
AMS
VABK
VABK
Q4 25
$55.5M
$1.6B
Q3 25
$59.6M
$1.6B
Q2 25
$63.5M
$1.6B
Q1 25
$63.3M
$1.6B
Q4 24
$60.2M
$1.6B
Q3 24
$63.3M
$1.6B
Q2 24
$60.8M
$1.6B
Q1 24
$50.1M
$1.6B
Debt / Equity
AMS
AMS
VABK
VABK
Q4 25
0.72×
Q3 25
0.74×
Q2 25
0.78×
Q1 25
0.81×
Q4 24
0.81×
Q3 24
0.54×
Q2 24
0.57×
Q1 24
0.68×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AMS
AMS
VABK
VABK
Operating Cash FlowLast quarter
$-704.0K
$21.3M
Free Cash FlowOCF − Capex
$-2.7M
$20.8M
FCF MarginFCF / Revenue
-34.8%
138.2%
Capex IntensityCapex / Revenue
25.7%
3.9%
Cash ConversionOCF / Net Profit
3.58×
TTM Free Cash FlowTrailing 4 quarters
$-8.5M
$35.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AMS
AMS
VABK
VABK
Q4 25
$-704.0K
$21.3M
Q3 25
$1.7M
$6.0M
Q2 25
$-372.0K
$6.7M
Q1 25
$2.5M
$2.1M
Q4 24
$274.0K
$15.3M
Q3 24
$472.0K
$15.2M
Q2 24
$1.3M
$-6.4M
Q1 24
$-1.9M
$3.2M
Free Cash Flow
AMS
AMS
VABK
VABK
Q4 25
$-2.7M
$20.8M
Q3 25
$-2.0M
$5.9M
Q2 25
$-2.3M
$6.7M
Q1 25
$-1.5M
$1.8M
Q4 24
$-4.4M
$14.6M
Q3 24
$-407.0K
$15.1M
Q2 24
$70.0K
$-6.8M
Q1 24
$-3.0M
$3.1M
FCF Margin
AMS
AMS
VABK
VABK
Q4 25
-34.8%
138.2%
Q3 25
-28.3%
41.0%
Q2 25
-32.1%
47.6%
Q1 25
-24.7%
13.0%
Q4 24
-48.4%
100.4%
Q3 24
-5.8%
111.7%
Q2 24
1.0%
-53.0%
Q1 24
-58.4%
23.9%
Capex Intensity
AMS
AMS
VABK
VABK
Q4 25
25.7%
3.9%
Q3 25
51.6%
0.5%
Q2 25
26.9%
0.2%
Q1 25
65.7%
1.8%
Q4 24
51.4%
5.1%
Q3 24
12.6%
0.9%
Q2 24
17.2%
3.1%
Q1 24
22.7%
0.2%
Cash Conversion
AMS
AMS
VABK
VABK
Q4 25
3.58×
Q3 25
1.31×
Q2 25
1.59×
Q1 25
0.47×
Q4 24
3.35×
Q3 24
3.30×
Q2 24
0.36×
-1.54×
Q1 24
-15.67×
0.87×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AMS
AMS

Direct Patient Services$4.0M51%
Rental Income From Medical Services$2.7M35%
Pbrt Services$1.2M15%

VABK
VABK

Segment breakdown not available.

Related Comparisons